Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
A crystalline form of an anxiolytic compound
Abstract: The present invention provides a crystalline Form B of compound 1, and pharmaceutically compositions thereof. The present invention also provides methods of treating a disease (e.g., a disease of the central nervous system) using the pharmaceutical compositions.
WO2014138772A1 - WIPO (PCT) Application PCT/AU2013/000497 events 2013-03-15 Priority to US201361787436P 2013-03-15 Priority to US61/787,436 2013-04-12 Priority to AU2013204159 2013-04-12 Priority to AU2013204159A 2013-05-14 Application filed by Bionomics Limited 2014-09-18 Publication of WO2014138772A1